Growth inhibitory effects of Beclin1 gene on epithelial ovarian cancer SKOV3 cells.
- Author:
Zhen-ling DUAN
1
;
Zhi-lan PENG
;
Zan-hong WANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Apoptosis; genetics; Apoptosis Regulatory Proteins; genetics; metabolism; Beclin-1; Cell Line, Tumor; Cell Proliferation; Female; Humans; Membrane Proteins; genetics; metabolism; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; pathology; Recombinant Proteins; genetics; metabolism; Transfection
- From: Journal of Southern Medical University 2010;30(4):672-676
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the effect of Beclin1 overexpression on the growth of ovarian carcinoma cell line SKOV3 in vitro and in vivo.
METHODSThe recombinant plasmid pcDNA3.1/Beclin1 was constructed and transfected into SKOV3 cells via lipofectamine 2000. MTT assay was used to evaluate the effect of Beclin1 overexpression on the proliferation and growth of the transfected cells, whose apoptosis and autophagy were analyzed by flow cytometry. SKOV3 cells transfected with the plasmids pcDNA3.1/Beclin1 or pcDNA3.1 were inoculated subcutaneously in nude mice, and their carcinogenic and growth activities in vivo were evaluated.
RESULTSMTT assay showed that transfection with pcDNA3.1/Beclin1 significantly inhibited the proliferations of SKOV3 cells, with a cell inhibition rate of 58.68% (P<0.05). The transfection also resulted in a cell apoptosis rate of (21.26-/+3.89)%, significantly higher than that of pcDNA3.1 trasnfection (P<0.05). Flow cytomerty showed that pcDNA3.1/Beclin1 transfection of SKOV3 cells produced a significantly higher MDC fluorescent intensity than pcDNA3.1 transfection. The SKOV3 cells transfected with vector pcDNA3.1/Beclin1 also showed decreased carcinogenic activity in nude mice, with a growth inhibition rate of 50.27%.
CONCLUSIONBeclin1 overexpression can inhibit the proliferation and growth of SKOV3 cells in vitro and vivo, suggesting its potential role in gene therapy of ovarian carcinoma.